Human herpesviruses (HHVs) have a particularly high prevalence in certain high-risk populations and cause increased morbidity and mortality in patients with acquired immunodeficiency syndrome (AIDS). Screening and treating subclinical HHV infections reduce human immunodeficiency virus (HIV) infection incidence, disease progression, and transmission. However, there are few studies on HHVs, HIV coinfection rates, and their related risk factors. We aimed to clarify the prevalence of all eight HHVs in peripheral blood samples collected from HIV-positive patients, and explore the association of HHV infection in HIV-positive patients in an HIVseropositive population in Yunnan. We recruited 121 HIV-positive patients with highly active antiretroviral therapy (HAART) and 45 healthy individuals. All the eight HHVs were detected using polymerase chain reaction and their epidemiological information and clinical data were collected and statistically analyzed. A high prevalence of HHVs (89.3%) was observed in individuals with HIV infections and with herpes simplex virus (HSV)-2 (65.3%), and HSV-1 (59.5%) being the most common.
immunodeficiency syndrome (AIDS). 1 HIV infection is becoming a global health issue due to high morbidity and mortality, and comparatively the situation may be worse in Yunnan. By the end of 2016, approximately 93 437 people were estimated to be living with HIV in Yunnan. This province has been considered the epicenter of HIV-1 in China, and was the first to conduct highly active antiretroviral therapy (HARRT) in China. 2 The course of infection of HIV-1 is characterized by a long interval between initial infection and the onset of serious symptoms as T cell numbers are gradually reduced. HIV infection is associated with an increased risk for human herpesviruses (HHVs) and related diseases, such as AIDS-associated oral lymphoma and oral hairy leukoplakia. 3 HHVs belong to the Herpesviridae family and are widely distributed viruses that cause benign and malignant disease in animals and humans. They are ubiquitous and have a particularly high prevalence in certain high-risk populations, causing increased morbidity and mortality in patients with AIDS. 4 There are eight known herpes family viruses associated with human infection: herpes simplex virus (HSV) types 1 and 2, varicella-zoster virus (VZV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), human herpesvirus 6 (HHV-6), human herpesvirus 7 (HHV-7), and human herpesvirus 8 (HHV-8). These viruses have both epidemiologic and clinical interactions with HIV-1, which are associated with serious opportunistic infections and their reactivation predicts poor outcome. 5, 6 Normal host immune response may control and limit HHV replication, but reactivation of latent infection can result in severe opportunistic infections with high morbidity and mortality in immunocompromised subjects. 7, 8 Furthermore, some HHVs might interact with HIV-1 or have a role as a cofactor for HIV-1 progression, accelerating the replication of HIV-1. 9 At the same time, HIV-1 can facilitate acquisition and reactivation of HHVs as HIV-1 and HHVs are involved in a vicious cycle. 10 Prevalence rates and viral loads are influenced by the biological properties of the virus, method of detection, frequency of sampling, whether symptomatic or not, social behaviors, and immunological status of the patient. 11 Detection using polymerase chain reaction (PCR) assay shows that the frequencies of these viruses are wide-ranging across a variety of clinical samples [12] [13] [14] and are influenced by the degree of immunodepression, 15, 16 geography, and behavioral risk factors. [17] [18] [19] Suppression of HHV recurrence by cotherapy had a clinically significant effect on prolonged survival in some cohorts of HIV-infected patients. 20 Zhaotong is located on a drug transmission route far from the border between China and other Southeast Asian countries. It may be the smallest affected area of the Yunnan Province to have an external strain HIV-1 that is indigenous. The seroprevalence rates and predictive factors of HHV in the setting of HIV-1 infections in Zhaotong have not been explored. In this study, we aimed to identify the prevalence of all eight HHVs in peripheral blood samples collected from HIV-positive patients and explore the association of HHV infection in HIV-positive patients while adjusting for potential confounding factors.
| METHODS

| Study participants
A total of 121 HIV-positive patients were randomly selected from 2517 cases of HIV infection that were treated in The First People's Hospital of Zhaotong City from May 2015 to February 2016. At the same time, we recruited a control group of 45 healthy, HIV-negative subjects, matched for age at the time of examination. The inclusion criterion for both groups was that they be without symptoms of acute illness (fever, headache, sore throat, body aches, and diarrhea) and malignancy at the time of enrollment. The exclusion criterion included pregnancy, use of immunosuppressant medications, and administration of antiherpetic therapy within 1 week before the date of study enrollment. Plasma samples from all subjects were stored at − 80°C until DNA was extracted. The study was approved by the Ethics Committee of The First Affiliated Hospital of Kunming Medical University. Verbal consent was obtained from all the participants before enrollment in the study. 
| HHV infection detection
| Epidemiological information and clinical data
Data on the social-demographic characteristics of these participants as well as the informed consent to participate in this study were obtained from the enrolled participants during the face-to-face interview by the outpatient doctor. Clinical data were also collected from the hospital laboratory information system, including a blood biochemical analytical index and CD4 lymphocyte count. 
| Statistical analysis
| RESULTS
| Demographic characteristics of study participants
The 166 participants were from 11 different areas of the Zhaotong prefecture. Among the HIV-positive and healthy HIV-negative groups, the ratio of male to female participants was 77:44 in the HIV-positive group and 20:25 in the control group. The mean age of the participants was 42 ± 14.0 years in the HIV group and 40 ± 12.2 years in the control group. The majority of the subjects were in the age range 31 to 40 with some over 41 years of age, with a distribution of 38% and 46.3% in the HIV group, and 37.8% and 26.7% in the control group. The majority of the subjects were married, accounting for 73.6% in the HIV group and 66.7% in the control group, followed by unmarried (12.4% vs 28.9%), divorced (7.4% vs 2.2%), widowed (5.8% vs 2.2%), and other/unknown (0.8% vs 0.0%). No significant differences among demographic characteristics were observed between either groups. Sexual transmission was the main HIV infection route and several were infected by sharing drug needles.
| HHVs infection status
In total, among 108 HIV-positive individuals were positive for HHV with at least one HHV infection. The prevalence of HHV was higher (89.3%) in peripheral blood of HIV-positive group than the control group (62.2%). The most prevalent viruses in the HIV group were HSV-2 (65.3%) and HSV-1 (59.5%), followed by HHV-8 (42.2%), HHV-6 (32.2%), EBV (16.5%), HHV-7 (15.6%), HCMV (5.0%), and VZV (1.7%). In contrast, HHV-8 (28.9%) and HHV-6 (20.0%) were the most prevalent viruses in the control group, followed by HSV-1 (17.8%), HSV-2 (11.1%), HHV-7 (6.7%), and VZV (2.2%), but EBV and HCMV were not detected in this group ( Figure 1A ). There was not enough data on the seroprevalence of CMV and HCMV for accurate statistical analysis. Statistical analysis indicated that there were significant differences in the presence of HSV-1 (P < .001), HSV-2 (P < .001), and EBV (P < .01) between the two groups.
The number of double and triple HHV infections were 33 and 30 in HIV-positive group, respectively, higher than a single infection.
Three cases were found to have six HHV infections (one was negative for VZV and EBV and two showed failure to detect VZV and HCMV).
Coinfection with multiple HHVs was more likely to occur in the HIV group than in the control group, especially coinfection with more than two different HHVs (P < .001), and this difference was found to be statistically significant. However, the control group was more likely to be coinfected with only one HHV (P < .01) ( Figure 1B ). Age was the most relevant factor for single HHV infections in the HIV group and significant differences were observed for the risk of infection by HHV-1 (P < .001), HSV-2 (P = .049), HHV-6 (P < .01), and HHV-8 (P = .001) at different age stages ( Table 1 ). The infection rates among those older than 31 years were especially higher than among others. Marital status was another leading risk for HHV; infections | 297 likely to be infected (P < .001). Surprisingly, there were no significant differences in the seroprevalence of the eight HHVs with different WHO stages and durations of HIV infection, which were thought to be related to organism immunization.
| Related predictive factors in HIV group
The results of HHV detection showed that patients with HIV were more likely to have greater than 2 HHV infections with different viruses. Multiple HHV infections were found to be significantly associated with age, marital status, CD4 cell counts, and current HAART regimen in HIV-positive patients, but not related to HIV viral load and WHO stage ( Table 2 ). The proportion of coinfection with multiple viruses was higher in married and older adults (above 41 years old), indicating that they were at a greater risk of having multiple infections. Similarly, different medication regimens of HARRT were also shown to influence multiple HHV infections (P = .011). The patients simultaneously using NRTIs with NNRTIs were more likely to have multiple infections. Multiple HHV 
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The prevalence of HHVs was higher in the peripheral blood of HIV-positive individuals than in that of the control group. This finding is in accordance with those of other studies, likely because of the high sensitivity of our PCR assay. 21 The eight HHVs except VZV were more prevalent in HIV-positive patients than in the control group. HHVs infectivity of those partners. 24 Plasma HIV viral load, CD4 count, and HAART therapy influenced each case of herpesvirus infection in different ways. 5, 25 No significant correlations were observed between the rate of HHV shedding and CD4 cell count or plasma HIV-1 RNA level among the HAART-treated patients of previous studies 26, 27 and our study.
The consequences of universal access to HAART include a reduction in the number of deaths by AIDS and a reduction of the incidence of opportunistic diseases. 28 However, in this study, HHV incidence appeared to persist at a higher frequency. Regarding the impact of current HAART regimens for HHV infections, we can conclude that patients treated with PIs instead of NNRTIs were at the highest risk of HHV-6 infection. As a second-line treatment, PIs instead of NNRTIs have been included in the HAART regimen for patients with side effects or drug resistance. 29 These findings suggest that no single type of therapy is likely to reduce reactivation rates among all classes of herpesviruses. 25 
